Mental Illnesses

PsychoGenics stands at the forefront of preclinical mental illness research. Our state-of-the-art facilities, coupled with predictive rodent models and a large catalog of behavioral assays is unmatched in the industry. Our in-house-developed  SmartCube®  platform exemplifies our innovation and commitment to industrializing phenotypic drug discovery for mental illness therapies and providing data-rich insights. Partnering with us means tapping into an unparalleled blend of technological sophistication, bespoke solutions, and a stellar track record in mental illness drug discovery.